Shuttle Pharmaceuticals Holdings Inc   (SHPH)
Other Ticker:  
Price: $0.3803 $-0.01 -2.861%
Day's High: $0.4 Week Perf: -2.56 %
Day's Low: $ 0.38 30 Day Perf: -2.56 %
Volume (M): 17 52 Wk High: $ 2.75
Volume (M$): $ 6 52 Wk Avg: $0.83
Open: $0.38 52 Wk Low: $0.35

 Market Capitalization (Millions $) 6
 Shares Outstanding (Millions) 16
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -7
 Cash Flow (TTM) (Millions $) -5
 Capital Exp. (TTM) (Millions $) 0

Shuttle Pharmaceuticals Holdings Inc
Shuttle Pharmaceuticals Holdings Inc is a pharmaceutical company that specializes in the research, development, manufacturing, and distribution of drugs and medical products. The company focuses on developing innovative solutions to address various healthcare challenges. They have a diverse portfolio of products targeting different therapeutic areas, including cardiovascular health, respiratory disorders, infectious diseases, and more. Shuttle Pharmaceuticals aims to improve the quality of life for patients and provide effective treatments for various medical conditions. They also collaborate with other healthcare organizations and invest in research and development to bring new and advanced medications to the market.

   Company Address: One Research Court Rockville 20850 MD
   Company Phone Number: 403-4212   Stock Exchange / Ticker: NASDAQ SHPH
   SHPH is expected to report next financial results on March 14, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Shuttle Pharmaceuticals Holdings Inc

Shuttle Pharmaceuticals Holdings Inc. Reports Operating Deficit of $1.54478 Million for Q1 2023 Amid Earnings Season

As the earnings season for January to March 31, 2023, continues, many corporations have announced their respective results. The pharmaceutical industry, a significant player in the global market, has also been reporting their earnings. One company that has recently released its earnings report is Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc (SHPH), a rising player in the industry, has issued an operating deficit of $-1.54478 million for the first quarter of the 2023 earnings season. While the shareholders anticipate additional revenue sources to evolve in the near future, they are less interested in the corporation's current accomplishment.
It is not surprising that the company realized a net loss of $-0.975 million, which has extended from $-0.078 million in the financial quarter ending March 31, 2022. The shareholders' expectations of additional revenue streams reflect the investors' desire to see solid growth and profitability in the long run.
However, it is essential to understand that the pharmaceutical industry is highly competitive, which means that many significant companies operate in this space. These companies tend to have diversified product portfolios, expansive distribution networks, and significant marketing budgets, which can help secure their market share and profitability.
It is noteworthy that Shuttle Pharmaceuticals Holdings Inc is a rising player in the pharmaceutical industry, which means that the company is still finding its feet in the market. The most crucial measure of the company's growth and profitability in the long run will stem from the successful development, approval, and commercialization of its pipeline products.



About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com